SRP101 Antibody

What is SRP101 and what is its role in the SRP pathway?

SRP101 is the Saccharomyces cerevisiae homologue of the alpha-subunit of the SRP receptor (SR alpha). It functions as a 69-kDa peripheral membrane protein that shares 32% identity (54% chemical similarity) with its mammalian counterpart and contains a predicted GTP binding domain . SRP101 plays an essential role in the targeting of nascent secretory proteins to the endoplasmic reticulum (ER) membrane as part of the signal recognition particle pathway .

The protein works in conjunction with other SRP components to facilitate the co-translational targeting of proteins to the ER. Recent research has shown that SRP101 is associated with SRP complexes that contain the SR receptor, which binds with SRP complexes at the ER during translation . This association is critical for establishing the proper connection between ribosomes translating secretory proteins and the translocation machinery at the ER membrane.

What phenotypes are observed when SRP101 is disrupted?

Disruption of the SRP101 gene results in an approximately sixfold reduction in the growth rate of yeast cells . Cells with depleted or disrupted SRP101 show impaired translocation of both soluble and membrane proteins across the ER membrane . The severity of translocation defects varies for different proteins but generally resembles those observed in SRP-deficient cells .

In vivo pulse-chase assays demonstrate that in srp101 dM cells (containing mutations in the SRP101 gene), the translocation of SRP-dependent substrate proteins like DHC-αF (a model SRP-dependent substrate) is substantially delayed and plateaus at less than 50% efficiency, compared to nearly complete translocation in wild-type SRP101 cells . This indicates that functional SRP101 is required for efficient protein translocation into the ER.

How do researchers study SRP101 interactions with other SRP components?

Research into SRP101 interactions employs several experimental approaches:

• Pull-down experiments: These identify stable protein associations, as demonstrated by studies showing Ded1 association with SRP complexes that contain SRP101 .

• Genetic linkage analysis: Researchers use genetic approaches to establish functional relationships between SRP101 and other pathway components .

• Epitope tagging: SRP101-FLAG constructs are commonly used for detection and isolation of SRP101-containing complexes .

• In vivo pulse-chase assays: These measure the functional consequences of SRP101 mutations on protein translocation, using 35S-labeled model substrates followed by immunoprecipitation .

• Sucrose gradient analysis: This technique separates different cellular complexes to study the association of SRP101 with other components in their native state .

What experimental systems are used to manipulate SRP101 expression?

Researchers employ several systems to manipulate SRP101 expression for functional studies:

• Inducible promoter control: Placing SRP101 under the control of the GAL1 promoter allows for regulated expression in yeast, enabling studies of SRP101 depletion effects .

• CRISPR-Cas9 genome editing: This approach generates knockout cell lines to study the effects of complete SRP101 deletion. HeLa-Cas9 and 293T-Cas9 cells have been transduced with lentiviral targeting sgRNAs to create SRB (mammalian SR beta) knockout clones, with similar approaches applicable to SRP101 studies .

• Plasmid-based expression systems: Various plasmid constructs (e.g., p413, p415, p424) carrying wild-type or mutant SRP101 sequences under different promoters allow for controlled complementation studies .

• siRNA-mediated silencing: For studying temporary depletion effects, particularly useful in combination with knockout of interacting partners .

How can researchers effectively analyze SRP101-dependent protein translocation in vivo?

For robust assessment of SRP101-dependent protein translocation, researchers should implement a multi-faceted approach:

• Selection of appropriate reporter substrates: Use model substrates like DHC-αF, where the signal sequence of prepro-α-factor is replaced by the hydrophobic core of the dipeptidyl aminopeptidase B signal sequence to create an SRP-dependent substrate protein . The glycosylation status of these reporters provides a quantitative readout for targeting and translocation efficiency.

• Pulse-chase analysis protocol:

  • Grow cells to appropriate density in selective media (e.g., SCEG -Ura)

  • Shift to media lacking specific amino acids (SD -Ura-Cys-Met) for 30 minutes

  • Pulse label with 35S-labeled amino acids (100 μCi/ml) for 2 minutes

  • Chase with excess cold amino acids

  • Collect time points by flash freezing in liquid nitrogen

  • Process via immunoprecipitation and gel analysis

• Controls and validation:

  • Include Western blot analysis of microsomal fractions to confirm proper localization of translocation machinery components

  • Verify that observed defects are not due to lower levels of ER-localized SR in experimental vs. control cells

  • Use multiple model substrates with varying signal sequence properties to assess substrate-specific effects

What are the molecular mechanisms of SRP101 interaction with the SRP RNA component?

Recent research has revealed intriguing connections between SRP101 and the RNA components of the SRP machinery:

• RNA association: SRP101 has been found in complexes containing SCR1 RNA, the RNA component of yeast SRP . This association appears to be functionally significant for the SRP pathway.

• RNA-binding proteins and SRP101: The RNA helicase Ded1 is associated with SRP complexes that contain SRP101 . Experimental approaches to study these interactions include:

  • Pull-down experiments with IgG against Ded1 followed by Northern blot analysis or RT-PCR for SCR1 RNA

  • Sucrose gradient analysis to examine co-migration of SRP101, Ded1, and SCR1 RNA

• Functional interactions: The ATPase activity of RNA-binding proteins like Ded1 can be affected by SRP components, suggesting regulatory interactions within the SRP machinery. For example, SRP21 (another SRP component) inhibits the ATPase activity of Ded1 more strongly when associated with SCR1 RNA than with other RNAs .

• Experimental considerations:

  • RNA preparation methods affect the folding and homogeneity of SRP RNAs, which can influence interaction studies

  • Normalization of activity assays is essential for comparing different RNA preparations

How does the SRP101 GTPase domain contribute to protein targeting regulation?

While the search results don't provide detailed information specifically about SRP101's GTPase activity, its importance can be inferred:

• Structural features: SRP101 contains a GTP binding domain that is likely crucial for its function, similar to its mammalian counterpart . This domain is predicted to regulate the interaction cycle of the SRP receptor with other components.

• Experimental approaches:

  • Mutations in the GTP binding domain would be expected to disrupt proper SRP101 function

  • GTPase activity assays with purified components could reveal regulation mechanisms

  • Use of non-hydrolyzable GTP analogs can help isolate specific steps in the targeting pathway

• Coordinated GTPase activities: Research suggests that GTPase activities of SRP pathway components are coordinated for productive protein targeting. Similar to ATPase activity studies with Ded1 , investigations of SRP101's GTPase activity would need to account for interactions with other SRP components.

What distinguishes SRP101-dependent from SRP-independent protein targeting mechanisms?

Recent research has revealed important insights about the relationship between SRP-dependent and SRP-independent targeting:

• Redundant pathways: Studies have shown that "ribosome/nascent chain trafficking to the ER can operate via SRP pathway-independent mechanism(s)" at least in yeast . This redundancy provides cellular robustness but complicates research.

• Experimental approaches to distinguish pathways:

  • Genetic studies using SRP101 mutations that phenocopy genomic deletions of SRP genes

  • Combined depletion of multiple pathway components, such as simultaneous knockout of SRB (SR beta) and knockdown of SRA (SR alpha) to create SR-null cells

  • Analysis of specific substrate proteins with varying dependencies on the SRP pathway

• Cooperative stability mechanisms: Loss of one SRP receptor component (e.g., SRA) leads to destabilization of other components (e.g., SRB) . This must be accounted for when interpreting results from knockout or knockdown experiments.

• Temporal considerations: Protein half-life affects the timing of depletion studies - for example, SRA protein levels were substantially decreased (~90%) by 72h post-siRNA transfection and undetectable by 96h, despite maximal mRNA reduction at 24h .

How can researchers generate effective antibodies against SRP101 for biochemical studies?

While the search results don't specifically discuss antibody generation against SRP101, methodological approaches can be inferred from related studies:

• Epitope selection strategies:

  • Target unique, surface-exposed regions of SRP101 distinct from other SR components

  • Consider both N-terminal and C-terminal regions, as terminal epitopes are often accessible

  • Avoid the GTP-binding domain if cross-reactivity with other GTPases is a concern

• Expression systems for antigen production:

  • Bacterial expression systems for specific domains or peptide antigens

  • Yeast expression systems may provide more native-like folding for complex epitopes

  • Fusion tags (His, GST, MBP) can facilitate purification while potentially enhancing immunogenicity

• Validation approaches:

  • Western blot analysis comparing wild-type and SRP101-depleted cells

  • Immunoprecipitation followed by mass spectrometry for specificity confirmation

  • Immunofluorescence to verify expected ER/cytosolic distribution patterns

• Alternative approaches:

  • Epitope tagging strategies using FLAG or HA tags have proven successful for SRP101 detection (SRP101-FLAG constructs)

  • Consider using PCR cloning methods with specific restriction sites (e.g., BamHI and XhoI) as demonstrated for SRP components

What are the optimal cloning strategies for SRP101 constructs?

Based on successful approaches documented in the literature:

• Vector selection:

  • p413 plasmids containing HIS3 markers and ADH promoters have been used for SRP components

  • p424 vectors have been employed for related constructs

  • Consider the promoter strength needed for your specific application

• Cloning methodology:

  • PCR amplification of SRP101 with primers containing appropriate restriction sites

  • Common restriction sites include BamHI and XhoI, though alternative sites may be needed if these are present in SRP101

  • Always verify final constructs via sequencing to ensure no mutations were introduced during cloning

• Tag incorporation:

  • N-terminal or C-terminal epitope tags (HA, FLAG) facilitate detection and purification

  • Consider the potential impact of tags on protein function and localization

  • Position tags to minimize interference with functional domains

How do SRP101 mutations affect specific substrate proteins differently?

Research indicates that SRP101 disruption affects various proteins to different degrees:

• Substrate-specific effects: When SRP101 is depleted or mutated, the degree of translocation defect varies for different proteins . This suggests that some proteins are more strictly dependent on functional SRP101 than others.

• Model substrate systems:

  • DHC-αF provides a quantitative readout through its glycosylation status upon insertion into the ER

  • Other model systems include 3xHA-BirA-Bos1-opsin under the GPD promoter

• Experimental design for comparative analysis:

  • Express multiple substrate proteins in the same cellular background

  • Use pulse-chase analysis with immunoprecipitation to quantify translocation efficiency

  • Compare kinetics and steady-state levels of translocation for each substrate

What methods are most effective for analyzing SRP101 protein-protein interactions?

To comprehensively characterize SRP101 interactions with other cellular components:

• Co-immunoprecipitation approaches:

  • Use epitope-tagged versions of SRP101 (such as SRP101-FLAG)

  • Analyze both stable complexes and transient interactions through crosslinking

  • Include appropriate controls to distinguish specific from non-specific interactions

• Sucrose gradient analysis:

  • Separate cellular complexes based on size and density

  • Analyze fractions by Western blotting to detect co-migration of SRP101 with other components

  • Compare wild-type and mutant conditions to identify affected interactions

• Genetic approaches:

  • Analyze genetic interactions between SRP101 and other genes

  • Look for synthetic lethality or suppressor relationships that reveal functional connections

• Quantitative methods:

  • Mass spectrometry analysis of purified complexes can identify interaction partners and their stoichiometry

  • Compare immunoprecipitation results between different conditions to identify condition-specific interactions

How should researchers interpret conflicting SRP101 localization data?

When facing contradictory results regarding SRP101 localization or function:

• Consider protein stability effects: Research shows that loss of one SRP receptor component leads to destabilization and redistribution of others . For example, loss of SRB expression is accompanied by destabilization and redistribution of SRA .

• Investigate cooperative stability mechanisms: Knockdown of one component can affect protein levels of interacting partners without affecting their mRNA levels . This post-transcriptional regulation must be considered when interpreting localization data.

• Methodological considerations:

  • Fractionation protocols can affect the apparent distribution of membrane-associated proteins like SRP101

  • Epitope tags may influence localization in some contexts

  • Fixation methods for microscopy can alter the observed distribution patterns

• Reconciliation strategies:

  • Use multiple complementary techniques (biochemical fractionation, microscopy, functional assays)

  • Test multiple cell types or growth conditions

  • Consider the possibility of dynamic localization that changes under different cellular states

What controls are essential for SRP101 translocation assays?

To ensure reliable interpretation of SRP101 translocation studies:

• Essential controls for pulse-chase experiments:

  • Verify equivalent expression levels of reporter proteins between experimental conditions

  • Confirm that ER-localized translocation machinery components are present at normal levels

  • Include both SRP-dependent and SRP-independent substrates as internal controls

• Verification of mutant phenotypes:

  • Complement mutant strains with wild-type SRP101 to confirm that observed defects are specifically due to SRP101 mutation

  • Use multiple independent mutant strains or clones to rule out clone-specific effects

  • Quantify growth rates to correlate translocation defects with physiological impacts

• Technical considerations:

  • Optimize labeling conditions for each cell type and substrate

  • Ensure complete immunoprecipitation of target proteins

  • Validate the glycosylation status as a reliable readout for ER translocation

What are emerging approaches to study SRP101 function in complex cellular contexts?

Advanced technologies offer new opportunities for SRP101 research:

• Proximity labeling approaches: These could identify transient interactions during the targeting cycle, providing a dynamic view of SRP101 associations.

• Cryo-electron microscopy: High-resolution structural studies of SRP101 within the SRP receptor complex could reveal mechanistic details of its function.

• Single-molecule studies: These could track individual targeting events in real-time, revealing the kinetics and sequence of events during SRP101-mediated protein targeting.

• Integrative approaches: Combining genetic, biochemical, and imaging methods will provide a more comprehensive understanding of SRP101 function in the complex cellular environment.

• Comparative studies across species: Analysis of SRP101 homologs in different organisms could reveal evolutionarily conserved mechanisms and species-specific adaptations in the SRP pathway.

How can researchers analyze SRP101 function in the context of translational regulation?

Emerging evidence suggests connections between SRP pathway components and translational regulation:

• RNA helicase interactions: The finding that Ded1, an RNA helicase involved in translation initiation, associates with SRP complexes containing SRP101 suggests potential regulatory connections between targeting and translation .

• Experimental approaches:

  • Ribosome profiling in SRP101 mutant vs. wild-type cells

  • Analysis of translation efficiency for specific mRNAs in the presence or absence of functional SRP101

  • Investigation of potential mRNA interactions with SRP101-containing complexes

• Regulatory mechanisms: The observation that SRP components can regulate the ATPase activity of RNA-binding proteins like Ded1 suggests potential feedback mechanisms between targeting and translation that warrant further investigation.